Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2025 Oct;27(10):5844-5851.
doi: 10.1111/dom.16640. Epub 2025 Jul 23.

The association between inflammation and glucose levels in hospitalised patients with type 2 diabetes

Affiliations
Randomized Controlled Trial

The association between inflammation and glucose levels in hospitalised patients with type 2 diabetes

Mikkel T Olsen et al. Diabetes Obes Metab. 2025 Oct.

Abstract

Aims: Stress-induced hyperglycaemia can exacerbate existing diabetes. However, the relationship between inpatient inflammation and glucose levels is not well understood.

Materials and methods: This post hoc analysis utilised data from the DIATEC trial (N = 166), a two-arm randomised controlled trial comparing glucose management with real-time continuous glucose monitoring (CGM) or point-of-care glucose testing in non-intensive care unit (non-ICU) patients with type 2 diabetes treated with a basal-bolus insulin regimen. Inflammation was measured as C-reactive protein (CRP) levels daily, and its association with daily glycaemic outcomes and insulin doses was assessed.

Results: For every 100 mg/dL increase in CRP, time in range 3.9-10.0 mmol/L (70-180 mg/dL) decreased by 3.6%-points (95% CI: 1.2-6.1, p = 0.004). An interaction was found between high CRP (>75.0 mg/dL) and high HbA1c (>51.0 mmol/mol or 6.8%), associated with an 8.9%-point reduction in TIR (95% CI: 3.8-14.1). Time above range >10.0 mmol/L (>180 mg/dL) increased by 3.3%-points (95% CI: 0.8-5.8, p = 0.009), and mean glucose increased by 0.2 mmol/L (95% CI: 0.02-0.4) (4.0 mg/dL, 95% CI: 0.4-7.0) for every 100 mg/dL increase in CRP. No significant associations were found between CRP and time below range <3.9 mmol/L (<70 mg/dL), glycaemic variability, hypoglycaemic events, or total daily insulin dose (all p > 0.05).

Conclusions: Elevated CRP levels only modestly increased glucose levels. This suggests that inflammation during hospitalisation has a limited effect on glucose levels in non-ICU patients with type 2 diabetes.

Keywords: clinical trial; continuous glucose monitoring (CGM); insulin resistance; type 2 diabetes.

PubMed Disclaimer

References

REFERENCES

    1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978‐982.
    1. Olsen MT, Dungu AM, Klarskov CK, Jensen AK, Lindegaard B, Kristensen PL. Glycemic variability assessed by continuous glucose monitoring in hospitalized patients with community‐acquired pneumonia. BMC Pulm Med. 2022;22(1):83.
    1. Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284‐289.
    1. Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care. 2013;17:305.
    1. Mifsud S, Schembri EL, Gruppetta M. Stress‐induced hyperglycaemia. Br J Hosp Med. 2018;79(11):634‐639.

Publication types

MeSH terms